InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,738.17
(
-0.13%
)
US TECH 100
19,439.97
(
-0.71%
)
Dow Jones
42,313.00
(
0.33%
)
Brent Oil
72.01
(
1.49%
)
Bitcoin
65,891.45
(
1.09%
)
Post# of 253249
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 129496

Wednesday, 10/26/2011 5:20:42 PM

Wednesday, October 26, 2011 5:20:42 PM

Post# of 253249

All told, I do not expect the CONFIRM study to have much impact, if any, on Copaxone sales.

Assuming BG-12 is approved for 1st line (almost certain, imo), with current safety/efficacy profile, you don't think it will take market share and impact Copaxone sales? I do agree it won't happen in a day but cannot see how Copaxone sales will not decline whith BG-12 as a competitor.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up